N. Ai, In silico methods for predicting drug-drug interactions with cytochrome P-450s, transporters and beyond, Adv. Drug Deliv. Rev, vol.86, pp.46-60, 2015.

F. C. Bernstein, The Protein Data Bank: a computer-based archival file for macromolecular structures, J. Mol. Biol, vol.112, pp.535-542, 1977.

C. Bode, The nasty surprise of a complex drug-drug interaction, Drug Discov. Today, vol.15, pp.391-395, 2010.

G. Brändén, Structure-based ligand design to overcome CYP inhibition in drug discovery projects, Drug Discov. Today, vol.19, pp.905-911, 2014.

B. R. Brooks, CHARMM: a program for macromolecular energy, minimization, and dynamics calculations, J. Comput. Chem, vol.4, pp.187-217, 1983.

P. Carbonell, Stereo signature molecular descriptor, J. Chem. Inf. Model, vol.53, pp.887-897, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01601691

G. Cruciani, MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist, J. Med. Chem, vol.48, pp.6970-6979, 2005.

C. De-graaf, Catalytic site prediction and virtual screening of cytochrome P450 2D6 substrates by consideration of water and rescoring in automated docking, J. Med. Chem, vol.49, pp.2417-2430, 2006.

C. S. Ferguson and R. F. Tyndale, Cytochrome P450 enzymes in the brain: emerging evidence of biological significance, Trends Pharmacol. Sci, vol.32, pp.708-714, 2011.

J. U. Flanagan, Phe120 contributes to the regiospecificity of cytochrome P450 2D6: mutation leads to the formation of a novel dextromethorphan metabolite, Biochem J, vol.380, pp.353-360, 2004.

U. Haberthü-r and A. Caflisch, FACTS: fast analytical continuum treatment of solvation, J. Comput. Chem, vol.29, pp.701-715, 2008.

I. H. Hanna, Diversity in mechanisms of substrate oxidation by cytochrome P450 2D6. Lack of an allosteric role of NADPH-cytochrome P450 reductase in catalytic regioselectivity, J. Biol. Chem, vol.276, pp.39553-39561, 2001.

M. Heinig and D. Frishman, STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins, Nucleic Acids Res, vol.32, pp.500-502, 2004.

J. Hritz, Impact of plasticity and flexibility on docking results for cytochrome P450 2D6: a combined approach of molecular dynamics and ligand docking, J. Med. Chem, vol.51, pp.7469-7477, 2008.

M. Ingelman-sundberg, Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects, Pharmacol. Ther, vol.116, pp.496-526, 2007.

Y. Ito, Analysis of CYP2D6 substrate interactions by computational methods, J. Mol. Graph. Model, vol.26, pp.947-956, 2008.

I. Johansson and M. Ingelman-sundberg, Genetic polymorphism and toxicology-with emphasis on cytochrome p450, Toxicol. Sci, vol.120, pp.1-13, 2011.

A. Karatzoglou, kernlab-an S4 package for kernel methods in R, J. Stat. Softw, vol.11, pp.1-20, 2004.

C. A. Kemp, Validation of model of cytochrome P450 2D6: an in silico tool for predicting metabolism and inhibition, J. Med. Chem, vol.47, pp.5340-5346, 2004.

J. Kirchmair, Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms, J. Chem. Inf. Model, vol.52, pp.617-648, 2012.

S. B. Kirton, Impact of incorporating the 2C5 crystal structure into comparative models of cytochrome P450 2D6, Proteins, vol.49, pp.216-231, 2002.

B. Kjellander, Exploration of enzyme-ligand interactions in CYP2D6 & 3A4 homology models and crystal structures using a novel computational approach, J. Chem. Inf. Model, vol.47, pp.1234-1247, 2007.

M. Kuhn, Building predictive models in R using the caret package, J. Stat. Softw, vol.28, pp.1-26, 2008.

D. Lagorce, The FAF-Drugs2 server: a multistep engine to prepare electronic chemical compound collections, Bioinformatics, vol.27, 2011.

A. Liaw and M. Wiener, Classification and regression by randomForest, R News, vol.2, pp.18-22, 2002.

M. Livezey, Molecular analysis and modeling of inactivation of human CYP2D6 by four mechanism based inactivators, Drug Metab. Lett, vol.6, pp.7-14, 2012.

A. D. Mackerell, Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations, J. Comput. Chem, vol.25, pp.1400-1415, 2004.

J. D. Marechal, Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions, Br. J. Pharmacol, vol.153, pp.82-89, 2008.

J. Martinez-sanz, New QSAR models for human cytochromes P450, 1A2, 2D6 and 3A4 implicated in the metabolism of drugs. Relevance of dataset on model development, Mol. Informatics, vol.32, pp.573-577, 2013.

V. Y. Martiny and M. A. Miteva, Advances in molecular modeling of human cytochrome P450 polymorphism, J Mol Biol, vol.425, pp.3978-3992, 2013.

M. A. Miteva, Frog2: efficient 3D conformation ensemble generator for small compounds, Nucleic Acids Res, vol.38, pp.622-627, 2010.

M. A. Miteva, PCE: web tools to compute protein continuum electrostatics, Nucleic Acids Res, vol.33, pp.372-375, 2005.

G. Moroy, Toward in silico structure-based ADMET prediction in drug discovery, Drug Discov. Today, vol.17, pp.44-55, 2012.

G. M. Morris, AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility, J. Comput. Chem, vol.30, pp.2785-2791, 2009.

P. C. Nair and J. O. Miners, Molecular dynamics simulations: from structure function relationships to drug discovery, In Silico Pharmacol, vol.2, p.4, 2014.

M. J. Paine, Residues glutamate 216 and aspartate 301 are key determinants of substrate specificity and product regioselectivity in cytochrome P450 2D6, J. Biol. Chem, vol.278, pp.4021-4027, 2003.

N. Pinto and M. E. Dolan, Clinically relevant genetic variations in drug metabolizing enzymes, Curr. Drug Metab, vol.12, pp.487-497, 2011.

S. Porcelli, Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism, Expert Opin. Drug Metab. Toxicol, vol.7, pp.1101-1115, 2011.

. Rdevelopmentcoreteam, R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2009.

C. Rodriguez-antona and M. Ingelman-sundberg, Cytochrome P450 pharmacogenetics and cancer, Oncogene, vol.25, pp.1679-1691, 2006.

G. Rossato, Probing small-molecule binding to cytochrome P450 2D6 and 2C9: an in silico protocol for generating toxicity alerts, ChemMedChem, vol.5, pp.2088-2101, 2010.

P. Rowland, Crystal structure of human cytochrome P450 2D6, J. Biol. Chem, vol.281, pp.7614-7622, 2006.
DOI : 10.2210/pdb2f9q/pdb

M. Rueda, ALiBERO: evolving a team of complementary pocket conformations rather than a single leader, J. Chem. Inf. Model, vol.52, pp.2705-2714, 2012.

J. P. Ryckaert, Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes, J. Comput. Phys, vol.23, pp.327-341, 1977.

A. Sali, Evaluation of comparative protein modeling by MODELLER, Proteins, vol.23, pp.318-326, 1995.

C. Y. Shao, CypRules: a rule-based P450 inhibition prediction server, Bioinformatics, vol.31, pp.1869-1871, 2015.
DOI : 10.1093/bioinformatics/btv043
URL : https://academic.oup.com/bioinformatics/article-pdf/31/11/1869/17122159/btv043.pdf

T. Shimada, Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons, Drug Metab. Pharmacokinet, vol.21, pp.257-276, 2006.

S. C. Sim and M. Ingelman-sundberg, The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects, Hum. Genomics, vol.4, pp.278-281, 2010.

D. Singh, Novel advances in cytochrome P450 research, Drug Discov. Today, vol.16, pp.793-799, 2011.
DOI : 10.1016/j.drudis.2011.08.003

F. Stoll, Utility of protein structures in overcoming ADMETrelated issues of drug-like compounds, Drug Discov. Today, vol.16, pp.530-538, 2011.

O. Trott and A. J. Olson, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem, vol.31, pp.455-461, 2010.

J. D. Tyzack, Prediction of cytochrome P450 xenobiotic metabolism: tethered docking and reactivity derived from ligand molecular orbital analysis, J. Chem. Inf. Model, vol.53, pp.1294-1305, 2013.

K. Vanommeslaeghe, Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges, J. Chem. Inf. Model, vol.52, pp.3155-3168, 2012.

A. Volkamer, Combining global and local measures for structure-based druggability predictions, J. Chem. Inf. Model, vol.52, pp.360-372, 2012.
DOI : 10.1021/ci200454v

A. Wang, Crystal structure of human cytochrome P450 2D6 with prinomastat bound, J. Biol. Chem, vol.287, pp.10834-10843, 2012.
DOI : 10.1074/jbc.m111.307918
URL : http://www.jbc.org/content/287/14/10834.full.pdf

A. Wang, Contributions of ionic interactions and protein dynamics to cytochrome P450 2D6 (CYP2D6) substrate and inhibitor binding, J. Biol. Chem, vol.290, pp.5092-5104, 2015.
DOI : 10.1074/jbc.m114.627661
URL : http://europepmc.org/articles/pmc4335244?pdf=render

Y. Wang, PubChem's BioAssay Database, Nucleic Acids Res, vol.40, pp.400-412, 2012.
DOI : 10.1093/nar/gkt978
URL : https://doi.org/10.1093/nar/gkt978